Drugs & Aging

, Volume 19, Issue 11, pp 879–886 | Cite as

Potential Interactions between Herbal Medicines and Conventional Drug Therapies Used by Older Adults Attending a Memory Clinic

  • Julie M. Dergal
  • Jennifer L. Gold
  • Dara A. Laxer
  • Monica S. W. Lee
  • Malcolm A. Binns
  • Krista L. Lanctôt
  • Morris Freedman
  • Paula A. Rochon
Original Research Article

Abstract

Objective

Herbal medicines and conventional drug therapies are often taken in combination. The objective of our study was to identify the range of natural health products and conventional drug therapies used by older adults (aged 65 years and over) attending a memory clinic, and to specifically evaluate the frequency of potential interactions between herbal medicines and conventional drug therapies.

Design

We interviewed consecutive patients attending the Memory Disorders Clinic at the Baycrest Centre for Geriatric Care, a University of Toronto teaching hospital, between 4 July and 15 August 2000. Patients were asked to bring to their appointment all natural health products (i.e. herbal medicines, vitamins and minerals) and conventional drug therapies (i.e. prescription and over-the-counter) they were currently using. We collected information on current and previously used natural health products and current conventional drug therapies. Patients were classified as having the potential for an interaction if they were using a current herbal medicine in combination with a conventional drug therapy and the interaction had been reported previously in the medical literature.

Participants

We interviewed 195 consecutive patients attending the Memory Disorders Clinic at the Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada.

Results

Of the 195 patients in our sample, 33 (17%) were ‘current users’, 19 (10%) were ‘past users’, and 143 (73%) were ‘never users’ of herbal medicines. Among the 52 patients who were ‘current or past users’, the most frequently used herbal medicines were ginkgo (Ginkgo biloba) [39 users], garlic (n = 10), glucosamine sulphate (n = 9) and echinacea (n = 8). Among the 33 patients who were current users, the most commonly used herbal medicines were Ginkgo biloba (n = 22), glucosamine sulphate (n = 8) and garlic (n = 6). Among the 33 current users, we identified 11 potential herb-drug interactions in nine patients. The 11 herb-drug interactions we identified were between ginkgo and aspirin (acetylsalicylic acid) [n = 8], ginkgo and trazodone (n = 1), ginseng and amlodipine (n = 1) and valerian and lorazepam (n = 1).

Conclusions

Herbal medicines are widely used. Almost one-third of current users of herbal medicines were at risk of a herb-drug interaction. The most common potential herb-drug interaction was between ginkgo and aspirin. This finding has important potential implications because both of these products are regularly used by older people. Physicians and other healthcare providers should be aware of potential herb-drug interactions and should monitor and inform their patients accordingly.

Keywords

Aspirin Herbal Medicine Potential Interaction Amlodipine Trazodone 

Notes

Acknowledgements

Dr Paula Rochon was supported by a Career Investigator Award, Canadian Institutes of Health Research. Dr Morris Freedman was supported by the Saul A. Silverman Family Foundation, Toronto, Canada, as part of a Canada International Scientific Exchange. Jennifer Gold and Dara Laxer were supported by the Kunin-Lunenfeld Applied Research Unit and a Summer Research Studentship at the Baycrest Centre for Geriatric Care. Julie Dergal, Monica Lee, Malcolm Binns and Krista Lanctôt were supported by the Kunin-Lunenfeld Applied Research Unit. The authors have no conflicts of interest directly relevant to the content of this study.

References

  1. 1.
    Eisenberg D, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280(18): 1569–75PubMedCrossRefGoogle Scholar
  2. 2.
    Cupp M. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59: 1239–45PubMedGoogle Scholar
  3. 3.
    Gold JL, Laxer DA, Dergal JM, et al. Interactions between herbal and conventional drug therapy: a focus on dementia. Curr Opin Clin Nutr Metab Care 2001; 4(1): 29–34PubMedCrossRefGoogle Scholar
  4. 4.
    Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61(15): 2163–75PubMedCrossRefGoogle Scholar
  5. 5.
    Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136(1): 42–53PubMedGoogle Scholar
  6. 6.
    Edwards R. WHO project is under way. BMJ 1995; (311): 1569–70Google Scholar
  7. 7.
    Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134–8PubMedCrossRefGoogle Scholar
  8. 8.
    Health Canada. Final report of the advisory panel on natural health products: regulatory framework for natural health products. Report: Health Canada; 1998 May 13Google Scholar
  9. 9.
    Chandler F. Herbs: an everyday reference for health professionals. Nepan, Ontario: Canadian Pharmacists Association and Canadian Medical Association, 2000Google Scholar
  10. 10.
    Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract [letter]. N Engl J Med 1997; 336: 1108PubMedCrossRefGoogle Scholar
  11. 11.
    Galluzzi S, Zanetti O, Binetti G, et al. Coma in a patient with Alzheimer’s disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679–83PubMedCrossRefGoogle Scholar
  12. 12.
    Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance. JAMA 1996; 276: 606–7PubMedCrossRefGoogle Scholar
  13. 13.
    Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health care professionals. London: Pharmaceutical Press, 1996Google Scholar
  14. 14.
    Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer’s disease. J Am Geriatr Soc 1995; 43: 747–50PubMedGoogle Scholar
  15. 15.
    Hogan D, Ebly E. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord 1996; 10(2): 63–7PubMedCrossRefGoogle Scholar
  16. 16.
    Gold JL, Laxer DA, Rochon PA. Herbal remedies: a critical perspective [letter]. Ann R Coll Physicians Surg Can 2000; 33: 497Google Scholar
  17. 17.
    Ernst E. Herbal medicines: where is the evidence? BMJ 2000; 321: 395–6PubMedCrossRefGoogle Scholar
  18. 18.
    Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients’ perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000; 20(1): 83–7PubMedCrossRefGoogle Scholar
  19. 19.
    Barnes J, Mills SY, Abbot NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496–500PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  • Julie M. Dergal
    • 1
  • Jennifer L. Gold
    • 1
  • Dara A. Laxer
    • 1
  • Monica S. W. Lee
    • 1
  • Malcolm A. Binns
    • 2
  • Krista L. Lanctôt
    • 1
    • 3
    • 4
  • Morris Freedman
    • 5
  • Paula A. Rochon
    • 1
    • 6
  1. 1.KLARUBaycrest Centre for Geriatric CareTorontoCanada
  2. 2.Baycrest Centre for Geriatric CareRotman Research InstituteTorontoCanada
  3. 3.Departments of Psychiatry and PharmacologyUniversity of TorontoCanada
  4. 4.Department of Psychiatry and HOPE Research CentreSunnybrook and Women’s College Health Sciences CentreTorontoCanada
  5. 5.Behavioural Neurology Program and Rotman Research Institute, Baycrest Centre for Geriatric Care and Department of Medicine (Division of Neurology), Mt. Sinai Hospital, University Health NetworkUniversity of TorontoTorontoCanada
  6. 6.Departments of Medicine and Public Health SciencesUniversity of Toronto and Institute for Clinical Evaluative SciencesTorontoCanada

Personalised recommendations